Non‐Canonical Modulation of Vitamin D Receptor Signaling by Paclitaxel in Triple‐Negative Breast Cancer
- 14 October 2026
- journal article
- research article
- Published by Wiley in Archiv der Pharmazie
- Vol. 359 (10) , e70360
Abstract
Triple‐negative breast cancer (TNBC) is characterized by a highly aggressive phenotype and limited therapeutic options. This study investigated whether the vitamin D receptor (VDR) modulates aggressiveness and chemotherapeutic response in TNBC and explored its interaction with paclitaxel (PTX) in the presence of a non‐hypercalcemic vitamin D analogue (UVB1). Functional cellular assays, orthotopic murine models, and computational approaches were integrated using murine 4T1 and human MDA‐MB‐468 TNBC cells with differential VDR expression, including PTX‐resistant models. The results show that VDR overexpression reduced invasive capacities in vitro and pulmonary metastatic dissemination in vivo, and sensitized cells to PTX alone or combined with UVB1. 4T1‐PTX‐resistant cells exhibited elevated VDR levels and less aggressive features compared with wild‐type cells. Computational analyses revealed stable PTX binding to an allosteric site near the activation function‐2 domain of VDR, further stabilized by UVB1. Functional assays demonstrated that the combination of PTX and UVB1 enhanced the transcriptional activity of VDR compared with UVB1 treatment alone. These findings identify VDR signaling as a modulator of tumor aggressiveness and PTX response in TNBC and support a model in which PTX contributes to nuclear receptor regulation, thus highlighting the relevance of non‐canonical drug–receptor interactions in shaping cellular responses to chemotherapy.Keywords
Funding Information
- Agencia Nacional de Promoción Científica y Tecnológica (2019‐01436)
- Agencia Nacional de Promoción Científica y Tecnológica (2018‐01678)
- Agencia Nacional de Promoción Científica y Tecnológica (2021‐I‐A‐00144)
- Secretaría General de Ciencia y Tecnología , Universidad Nacional del Sur (24/B285)
- Secretaría General de Ciencia y Tecnología , Universidad Nacional del Sur (24/B351)
- Fundación Florencio Fiorini (2021)
This publication has 40 references indexed in Scilit:
- MDAnalysis 2.0 and beyond: fast and interoperable, community driven simulation analysisBiophysical Journal, 2022
- Loss of the Vitamin D Receptor in Human Breast Cancer Cells Promotes Epithelial to Mesenchymal Cell Transition and Skeletal ColonizationJournal of Bone and Mineral Research, 2019
- Breast Cancer TreatmentJAMA, 2019
- Investigation of the antitumor activity and toxicity of long-circulating and fusogenic liposomes co-encapsulating paclitaxel and doxorubicin in a murine breast cancer animal modelBiomedicine & Pharmacotherapy, 2019
- Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancerBreast Cancer Research and Treatment, 2016
- Immunological Effects of Conventional Chemotherapy and Targeted Anticancer AgentsCancer Cell, 2015
- Vitamin D Analogue: Potent Antiproliferative Effects on Cancer Cell Lines and Lack of Hypercalcemic ActivityArchiv der Pharmazie, 2015
- The Amber biomolecular simulation programsJournal of Computational Chemistry, 2005
- The role of MyD88 and TLR4 in the LPS-mimetic activity of TaxolEuropean Journal of Immunology, 2001
- VMD: Visual molecular dynamicsJournal of Molecular Graphics, 1996